Kenvue Inc. is a consumer health company globally.
| Revenue (TTM) | $15.29B |
| Gross Profit (TTM) | $8.96B |
| EBITDA | $3.47B |
| Operating Margin | 21.60% |
| Return on Equity | 15.70% |
| Return on Assets | 7.07% |
| Revenue/Share (TTM) | $7.97 |
| Book Value | $5.62 |
| Price-to-Book | 3.17 |
| Price-to-Sales (TTM) | 2.20 |
| EV/Revenue | 2.706 |
| EV/EBITDA | 12.91 |
| Quarterly Earnings Growth (YoY) | 46.90% |
| Quarterly Revenue Growth (YoY) | 4.50% |
| Shares Outstanding | $1.92B |
| Float | $1.92B |
| % Insiders | 0.05% |
| % Institutions | 95.45% |
Volatility is currently expanding